UPDATE 1-FDA panel backs limiting use of testosterone replacement drugs
September 17, 2014 at 18:01 PM EDT
Sept 17 (Reuters) - Testosterone replacement therapies should be reserved for men with specific medical conditions that impair function of the testicles, an advisory panel to the U.S. Food and Drug Administration concluded on Wednesday.
